CSIMarket
 
Lexaria Bioscience Corp   (NASDAQ: LEXX)
 

News about Lexaria Bioscience




Lexaria Bioscience Corp*s Innovative Drug-Delivery System Shines in Second Quarter of 2024 Efforts
Apr 10 2024
Lexaria Bioscience Corp has been making waves in the pharmaceutical industry with its groundbreaking drug-delivery system that has the potential to re...

Lexaria Bioscience Corp*s Game-Changing Drug-Delivery System Unveiled, Unlocking the Future of Medical Treatments
Jan 14 2024
Lexaria Bioscience Corp (NASDAQ: LEXX) has recently unveiled its groundbreaking proprietary drug-delivery system, signaling a potential revolution in ...

Lexaria Bioscience Corp*s Revolutionary Drug-Delivery System: The Future of Medical Breakthroughs and Profitability.
Jan 11 2024
as Profitable: Lexaria Bioscience s Breakthrough Drug-Delivery System Revolutionizes Medical Treatments Lexaria Bioscience Corp. (NASDAQ: LEXX) h...

Lexaria Bioscience Corp. Revolutionizes Drug Delivery for Type 2 Diabetes Treatment
Jan 09 2024
Lexaria Bioscience Corp. (NASDAQ: LEXX) has recently announced an exciting breakthrough in drug delivery technology, elevating the efficacy and delive...

Vanishing Deficit: Lexaria Bioscience Corp*s Remarkable Financial Turnaround Signals a Promising Future 2.
Nov 21 2023
Lexaria Bioscience Corp, a renowned pharmaceutical company, has recently showcased a significant improvement in its financial performance. In the most...









Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com